Nanox integrates FDA-cleared population health AI solutions into its Second Opinions service

Nanox将FDA批准的人口健康AI解决方案整合到其第二意见服务中

New AI capabilities available to patients who submit chest and abdominal CT scans for second opinions

提交胸部和腹部CT扫描以获得第二意见的患者可以使用新的AI功能

Offering the power of Artificial Intelligence to their second opinion CT report to promote early detection of chronic conditions

为他们的第二意见CT报告提供人工智能的力量，以促进慢性病的早期发现

PETACH TIKVA, Israel, June 05, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that its deep-learning medical imaging analytics subsidiary, Nanox AI Ltd., has launched an artificial intelligence (AI) functionality in the Second Opinions online medical consultation service.

以色列佩塔赫·蒂科瓦（PETACH TIKVA），2024年6月5日（Global NEWSWIRE）--创新医学成像技术公司NANO-X IMAGING LTD（“Nanox”或“公司”，纳斯达克：NNOX）今天宣布，其深度学习医学成像分析子公司Nanox AI LTD.在第二意见在线医疗咨询服务中推出了人工智能（AI）功能。

Second Opinions is a platform provided by USARAD Holdings INC, a subsidiary of Nano-X Imaging Ltd., that provides teleradiology services. The platform connects patients with radiologists and other subspecialty physicians for additional consultation on their medical diagnoses. Second Opinions has integrated three of Nanox.AI’s FDA 510(k)-cleared AI solutions, enabling patients to conveniently get second opinions from experts in various medical and surgical subspecialties including radiology, neurology, oncology and orthopedic surgery.

第二个观点是USARAD Holdings INC提供的平台，USARAD Holdings INC是Nano-X Imaging Ltd.的子公司，提供远程放射服务。该平台将患者与放射科医生和其他专科医生联系起来，以便就其医疗诊断进行更多咨询。第二种观点整合了Nanox的三种观点。AI的FDA 510（k）批准的AI解决方案，使患者能够方便地从各种医疗和外科亚专业的专家那里获得第二意见，包括放射学，神经病学，肿瘤学和整形外科。

The integration of Nanox.AI’s tools is intended to promote the early detection of chronic conditions on chest and abdominal CT scans:.

Nanox的集成。AI的工具旨在促进胸部和腹部CT扫描中慢性病的早期发现：。

AI Cardiac solution (HealthCCSng) detects coronary artery calcium, an early sign of coronary artery disease

AI心脏溶液（HealthCCSng）检测冠状动脉钙，这是冠状动脉疾病的早期征兆

AI Bone solution (HealthOST) assesses bone mineral density, and highlights vertebral spine compression fractures which can indicate risk of osteoporosis

AI Bone solution（HealthOST）评估骨矿物质密度，并突出显示脊柱压缩性骨折，这可能表明骨质疏松症的风险

AI Liver solution (HealthFLD) measures liver density, which can indicate fatty liver disease

AI肝脏溶液（HealthFLD）测量肝脏密度，这可能表明脂肪肝疾病

These AI-driven insights are reviewed and approved by Second Opinions physicians and incorporated into reports for patients who submit eligible chest and abdominal CT scans.

这些人工智能驱动的见解由第二意见医生审查和批准，并纳入提交符合条件的胸部和腹部CT扫描的患者的报告中。

“We are excited to bring AI-powered, early detection through the Second Opinions platform to patients seeking peace of mind concerning their health and diagnoses,” said Erez Meltzer, Nanox Chief Executive Officer. “The integration of Nanox.AI’s solutions into the Second Opinions service will help empower radiologists and other healthcare providers by providing them with advanced AI tools that aim to improve patient outcomes.

Nanox首席执行官Erez Meltzer说：“我们很高兴通过第二意见平台为寻求健康和诊断方面的安宁的患者带来人工智能支持的早期检测。”。“将Nanox.AI的解决方案集成到第二意见服务中，将为放射科医生和其他医疗保健提供者提供旨在改善患者预后的先进人工智能工具，从而帮助他们增强能力。

We will continue exploring opportunities to leverage our AI technology to promote accessible early diagnosis and preventative management.”.

我们将继续探索利用人工智能技术促进早期诊断和预防管理的机会。”。

Learn more about Second Opinions and its new AI capabilities at Artificial Intelligence (AI) Service - Second Opinions.

在人工智能（AI）服务-Second Opinions了解更多关于Second Opinions及其新AI功能的信息。

About USARAD

关于使用

USARAD is a U.S.-based teleradiology company with a network of radiologists, certified by the American Board of Radiology. USARAD provides imaging interpretation and database services to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities and multi-specialty physician groups in the U.S and additional countries, improving service levels, streamlining practice economics and enhancing physician efficiency..

USARAD是一家总部位于美国的远程放射学公司，拥有美国放射学委员会认证的放射科医师网络。USARAD为美国和其他国家的放射学实践、医院、诊所、诊断成像中心、紧急护理设施和多专业医师团体提供成像解释和数据库服务，提高服务水平，简化实践经济并提高医生效率。。

About Nanox.AI

关于Nanox。人工智能

Nanox AI is the deep-learning medical imaging analytics subsidiary of Nanox. Nanox.AI solutions are developed to target highly prevalent chronic and acute diseases affecting large populations around the world. Leveraging AI technology, Nanox AI helps clinicians extract valuable and actionable clinical insights from routine medical imaging that otherwise may go unnoticed, potentially initiating further medical assessment to establish individual preventative care pathways for patients.

Nanox AI是Nanox的深度学习医学成像分析子公司。纳诺克斯。AI解决方案旨在针对影响世界各地大量人群的高度流行的慢性和急性疾病。利用人工智能技术，Nanox AI可以帮助临床医生从常规医学成像中提取有价值且可行的临床见解，否则这些见解可能会被忽视，从而有可能启动进一步的医学评估，为患者建立个人预防保健途径。

For more information, please visit https://www.nanox.vision/ai..

有关更多信息，请访问https://www.nanox.vision/ai..

About Nanox

关于Nanox

Nanox (NASDAQ: NNOX) is focused on applying its proprietary medical imaging technology and solutions to make diagnostic medicine more accessible and affordable across the globe. Nanox’s vision is to increase access, reduce costs and enhance the efficiency of routine medical imaging technology and processes, in order to improve early detection and treatment, which Nanox believes is key to helping people achieve better health outcomes, and, ultimately, to save lives.

Nanox（纳斯达克：NNOX）专注于应用其专有的医学成像技术和解决方案，使诊断医学在全球范围内更容易获得和负担得起。Nanox的愿景是增加获取机会，降低成本，提高常规医学成像技术和流程的效率，以改进早期检测和治疗，Nanox认为这是帮助人们取得更好健康结果的关键，并最终挽救生命。

The Nanox ecosystem includes Nanox.ARC— a multi-source Digital Tomosynthesis system that is cost-effective and user-friendly; an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic disease (Nanox.AI); a cloud-based infrastructure (Nanox.CLOUD); and a proprietary decentralized marketplace, through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts; and a comprehensive teleradiology services platform (Nanox.MARKETPLACE).

Nanox生态系统包括Nanox。ARC-一个具有成本效益和用户友好的多源数字层析合成系统；基于AI的一套算法，可增加常规CT成像的读数，以突出通常与慢性疾病相关的早期体征（Nanox.AI）；基于云的基础设施（Nanox.cloud）；通过Nanox的子公司USARAD Holdings Inc.建立了一个专有的分散式市场，为放射学和心脏病学专家提供远程访问；以及一个全面的远程放射服务平台（Nanox.MARKETPLACE）。

Together, Nanox’s products and services create a worldwide, innovative, and comprehensive solution that connects medical imaging solutions, from scan to diagnosis. For more information, please visit www.nanox.vision..

Nanox的产品和服务共同创造了一个全球范围的、创新的、全面的解决方案，将医学成像解决方案从扫描连接到诊断。有关更多信息，请访问www.nanox.vision。。

Contacts

联系人

Media Contact:

媒体联系人：

Ben Shannon

本·香农

ICR Westwicke

ICR Westwicke

NanoxPR@icrinc.com

NanoxPR@icrinc.com

Investor Contact:

投资者联系人：

Mike Cavanaugh

迈克·卡瓦诺

ICR Westwicke

ICR Westwicke

mike.cavanaugh@westwicke.com

mike.cavanaugh@westwicke.com